CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX-RESTRICTED CYTOTOXIC T-LYMPHOCYTES ARE NOT NECESSARY FOR HETEROTYPIC IMMUNITY TO INFLUENZA

被引:38
作者
BENDER, BS
BELL, WE
TAYLOR, S
SMALL, PA
机构
[1] UNIV FLORIDA,COLL MED,DEPT MED,GAINESVILLE,FL
[2] UNIV FLORIDA,COLL MED,DEPT IMMUNOL & MED MICROBIOL,GAINESVILLE,FL
关键词
D O I
10.1093/infdis/170.5.1195
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mice transgenic for beta(2)-microglobulin deletion (beta(2)M-/-) were immunized intranasally with either a recombinant vaccinia virus that expressed both nucleoprotein and interleukin-2 or by infection with H3N2 influenza virus; 3-4 weeks later they were challenged with H1N1 influenza virus. The immunized beta(2)M-/- mice had increased survival and enhanced clearance of virus relative to nonimmune controls. This protection correlated with the development of class II major histocompatibility complex-restricted pulmonary cytotoxic T lymphocyte activity and nasal IgA anti-nucleoprotein antibody. Heterotypic immunity can therefore be generated by a mechanism that does not involve class I major histocompatibility complex-restricted T cells.
引用
收藏
页码:1195 / 1200
页数:6
相关论文
共 37 条
[1]   THE ROLES OF INFLUENZA-VIRUS HEMAGGLUTININ AND NUCLEOPROTEIN IN PROTECTION - ANALYSIS USING VACCINIA VIRUS RECOMBINANTS [J].
ANDREW, ME ;
COUPAR, BEH ;
BOYLE, DB ;
ADA, GL .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1987, 25 (01) :21-28
[2]   HIGHLY LYTIC CD8+, ALPHA,BETA T-CELL RECEPTOR CYTOTOXIC T-CELLS WITH MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS-I ANTIGEN-DIRECTED CYTOTOXICITY IN BETA(2)-MICROGLOBULIN, MHC CLASS-I-DEFICIENT MICE [J].
APASOV, S ;
SITKOVSKY, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (07) :2837-2841
[3]   TRANSGENIC MICE LACKING CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX-RESTRICTED T-CELLS HAVE DELAYED VIRAL CLEARANCE AND INCREASED MORTALITY AFTER INFLUENZA-VIRUS CHALLENGE [J].
BENDER, BS ;
CROGHAN, T ;
ZHANG, LP ;
SMALL, PA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (04) :1143-1145
[4]   HETEROTYPIC IMMUNE MICE LOSE PROTECTION AGAINST INFLUENZA-VIRUS INFECTION WITH SENESCENCE [J].
BENDER, BS ;
SMALL, PA .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (04) :873-880
[5]   RECOGNITION OF CLONED INFLUENZA-VIRUS HEMAGGLUTININ GENE-PRODUCTS BY CYTOTOXIC LYMPHOCYTES-T [J].
BENNINK, JR ;
YEWDELL, JW ;
SMITH, GL ;
MOSS, B .
JOURNAL OF VIROLOGY, 1986, 57 (03) :786-791
[6]   CLEARANCE OF INFLUENZA-VIRUS RESPIRATORY-INFECTION IN MICE LACKING CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX-RESTRICTED CD8+ T-CELLS [J].
EICHELBERGER, M ;
ALLAN, W ;
ZIJLSTRA, M ;
JAENISCH, R ;
DOHERTY, PC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (04) :875-880
[7]   HOMOTYPIC AND HETEROTYPIC PROTECTION AGAINST INFLUENZA-VIRUS INFECTION IN MICE BY RECOMBINANT VACCINIA VIRUS EXPRESSING THE HEMAGGLUTININ OR NUCLEOPROTEIN GENE OF INFLUENZA-VIRUS [J].
ENDO, A ;
ITAMURA, S ;
IINUMA, H ;
FUNAHASHI, S ;
SHIDA, H ;
KOIDE, F ;
NEROME, K ;
OYA, A .
JOURNAL OF GENERAL VIROLOGY, 1991, 72 :699-703
[8]  
EPSTEIN SL, 1993, J IMMUNOL, V150, P5484
[9]   PREVENTION OF VACCINIA VIRUS-INFECTION IN IMMUNODEFICIENT MICE BY VECTOR-DIRECTED IL-2 EXPRESSION [J].
FLEXNER, C ;
HUGIN, A ;
MOSS, B .
NATURE, 1987, 330 (6145) :259-262
[10]   SAFETY AND IMMUNOGENICITY OF A RECOMBINANT PROTEIN INFLUENZA-A VACCINE IN ADULT HUMAN VOLUNTEERS AND PROTECTIVE EFFICACY AGAINST WILD-TYPE H1N1 VIRUS CHALLENGE [J].
FRIES, LF ;
DILLON, SB ;
HILDRETH, JEK ;
KARRON, RA ;
FUNKHOUSER, AW ;
FRIEDMAN, CJ ;
JONES, CS ;
CULLETON, VG ;
CLEMENTS, ML .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (03) :593-601